Targeted DNA-seq and RNA-seq of Reference Samples with Short-read and Long-read Sequencing
-
Published:2024-08-16
Issue:1
Volume:11
Page:
-
ISSN:2052-4463
-
Container-title:Scientific Data
-
language:en
-
Short-container-title:Sci Data
Author:
Gong BinshengORCID, Li Dan, Łabaj Paweł P.ORCID, Pan Bohu, Novoradovskaya Natalia, Thierry-Mieg Danielle, Thierry-Mieg JeanORCID, Chen Guangchun, Bergstrom Lucas Anne, LoCoco Jennifer S., Richmond Todd A.ORCID, Tseng Elizabeth, Kusko RebeccaORCID, Happe Scott, Mercer Timothy R., Pabón-Peña Carlos, Salmans Michael, Tilgner Hagen U., Xiao Wenzhong, Johann Donald J., Jones WendellORCID, Tong WeidaORCID, Mason Christopher E.ORCID, Kreil David P., Xu JoshuaORCID
Abstract
AbstractNext-generation sequencing (NGS) has revolutionized genomic research by enabling high-throughput, cost-effective genome and transcriptome sequencing accelerating personalized medicine for complex diseases, including cancer. Whole genome/transcriptome sequencing (WGS/WTS) provides comprehensive insights, while targeted sequencing is more cost-effective and sensitive. In comparison to short-read sequencing, which still dominates the field due to high speed and cost-effectiveness, long-read sequencing can overcome alignment limitations and better discriminate similar sequences from alternative transcripts or repetitive regions. Hybrid sequencing combines the best strengths of different technologies for a more comprehensive view of genomic/transcriptomic variations. Understanding each technology’s strengths and limitations is critical for translating cutting-edge technologies into clinical applications. In this study, we sequenced DNA and RNA libraries of reference samples using various targeted DNA and RNA panels and the whole transcriptome on both short-read and long-read platforms. This study design enables a comprehensive analysis of sequencing technologies, targeting protocols, and library preparation methods. Our expanded profiling landscape establishes a reference point for assessing current sequencing technologies, facilitating informed decision-making in genomic research and precision medicine.
Publisher
Springer Science and Business Media LLC
Reference62 articles.
1. Sequencing Quality Control 2. Nature Biotechnology Web Collection https://www.nature.com/collections/SEQC2 (2021). 2. Wang, Z., Gerstein, M. & Snyder, M. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 10, 57–63 (2009). 3. Byron, S. A., Van Keuren-Jensen, K. R., Engelthaler, D. M., Carpten, J. D. & Craig, D. W. Translating RNA sequencing into clinical diagnostics: opportunities and challenges. Nat Rev Genet 17, 257–271 (2016). 4. Ye, H., Meehan, J., Tong, W. & Hong, H. Alignment of Short Reads: A Crucial Step for Application of Next-Generation Sequencing Data in Precision Medicine. Pharmaceutics 7, 523–541 (2015). 5. Mittempergher, L. et al. MammaPrint and BluePrint Molecular Diagnostics Using Targeted RNA Next-Generation Sequencing Technology. J Mol Diagn 21, 808–823 (2019).
|
|